Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OctoPlus, a drug delivery company, has entered into a feasibility agreement with a US based pharmaceutical firm regarding the usage of its controlled release drug delivery technology.
Subscribe to our email newsletter
As per the pact, OctoPlus is expected to develop a controlled release formulation of an undisclosed compound using its proprietary drug delivery technology PolyActive, a biodegradable polymeric drug delivery system.
OctoPlus claimed that its biodegradability, safety record and linear release properties make PolyActive an appropriate technology for the controlled release of proteins and lipophilic small molecules.
If the evaluation is successful, both the companies are further planning to sign a full process development, manufacturing and licensing agreement,